Choc the post is consistent to what the company is communicating to shareholders if you contact them. What he/she is most probably referring to above is that pharmas have continued to view suda as a distribution company and keep proposing deals based on royalties. Suda won't do deals with pharmas without upfront, milestone and royalty components however and word has it that it's starting to sink in.
On the Bright Side, page-45
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $200.6M | |||
| Open | High | Low | Value | Volume |
| 18.8¢ | 19.0¢ | 18.5¢ | $115.0K | 609.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 226209 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 791369 | 7 |
View Market Depth
| Last trade - 15.59pm 08/11/2024 (20 minute delay) ? |
| ALA (ASX) Chart |